Macrophage WDFY3, a protector against autoimmunity.
Xun WuZiyi WangKatherine R CroceFang LiJian CuiVivette D D'AgatiRajesh Kumar SoniShareef KhalidDanish SaleheenIra TabasAi YamamotoHanrui ZhangPublished in: bioRxiv : the preprint server for biology (2024)
Efficient efferocytosis is essential for maintaining homeostasis. Excessive apoptotic cell (AC) death and impaired macrophage efferocytosis lead to autoantigen release and autoantibody production, immune activation, and organ damage. It remains unclear whether these immunogenic autoantigens are the sole cause of increased autoimmunity or if efferocytosis of ACs directly influences macrophage function, impacting their ability to activate T cells and potentially amplifying autoimmune responses. Additionally, it has not been established if enhancing macrophage efferocytosis or modulating macrophage responses to AC engulfment can be protective in autoimmune-like disorders. Our previous work showed WDFY3 is crucial for efficient macrophage efferocytosis. This study reveals that myeloid knockout of Wdfy3 exacerbates autoimmunity in young mice with increased AC burden by systemic injections of ACs and in middle-aged mice developing spontaneous autoimmunity, whereas ectopic overexpression of WDFY3 suppresses autoimmunity in these models. Macrophages, as efferocytes, can activate T cells and the inflammasome upon engulfing ACs, which are suppressed by overexpressing WDFY3. This work uncovered the role of WDFY3 as a protector against autoimmunity by promoting macrophage efferocytosis thus limiting autoantigen production, as well as mitigating T cell activation and inflammasome activation.
Keyphrases
- adipose tissue
- acute coronary syndrome
- middle aged
- celiac disease
- multiple sclerosis
- stem cells
- signaling pathway
- type diabetes
- cell death
- oxidative stress
- metabolic syndrome
- transcription factor
- single cell
- insulin resistance
- bone marrow
- risk factors
- cell proliferation
- dendritic cells
- body mass index
- immune response
- cell therapy
- mesenchymal stem cells
- drug induced
- skeletal muscle
- weight loss